Last updated: 2026-09-16 20:46:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $267.34, with a market capitalization of $641.80B and a P/E ratio of 30.61. Over the past 52 weeks, its price has ranged from $173.33 to $281.07. This page covers its latest market performance, valuation, price trends and company information.
$641.80B | |
$266.81 | |
$281.07 | |
$46.25 | |
$267.20 | |
3.47M | |
7.60M | |
30.61 | |
$281.07 | |
$173.33 | |
1.96% | |
-- |
Johnson & Johnson (JNJ) is trading at $267.39 in after-hours trading as of 2026-09-16 20:44:00, up 0.07% ($0.19) from the regular-session close of $267.20.
After-hours trading shows how investors are pricing JNJ after the regular session closes. The current after-hours price is near the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Johnson & Johnson (JNJ) moved from $275.23 to $267.34, representing a decline of 2.87% ($7.89).
The stock traded between $260.68 and $277.80 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 5.46 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 87.3%
JNJ is currently trading at $267.34, placing it 87.3% of the way from its 52-week low of $173.33 to its 52-week high of $281.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.